Blind ? [Two-Stage / GS Designs]

posted by Ohlbe – France, 2010-10-28 01:37 (5351 d 00:45 ago) – Posting: # 6092
Views: 15,984

Dear Jack,

What's probably confusing to a number of people following this thread is what you exactly mean with "blind". In clinical trials this is usually meant as not knowing which treatment is administered to which patient/subject. In a BE trial this usually only applies to the bioanalytical lab. You can't run the statistical analysis without unblinding (even if you call the products A and B and don't tell the statistician which is the test and which is the reference, it won't make any difference).

So to keep it short, a question from a non-statistician: what do you exactly mean by blinded in this particular context ? Blinded to what ?

Regards
Ohlbe

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,671 registered users;
48 visitors (0 registered, 48 guests [including 12 identified bots]).
Forum time: 02:23 CEST (Europe/Vienna)

Medical researches can be divided into two sorts:
those who think that meta is better and those
who believe that pooling is fooling.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5